RERE
protein-codingarginine-glutamic acid dipeptide repeats, the group of Myb/SANT domain containing|Atrophins|GATA zinc finger domain containing
Gene summary
This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- ATN1L
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~496.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014857
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014857
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014857
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0014857
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100465
Submitter: ClinGen
*RERE* was first reported in relation to autosomal dominant complex neurodevelopmental disorder with or without congenital anomalies in 2016 (Fregeau et al., PMID: 27087320). *RERE*-related complex neurodevelopmental disorder with or without congenital anomalies most often presents with developmental delay, intellectual disability, and autism. Additional syndromic abnormalities, which are not always present, most commonly involve the eyes, heart, and genitourinary system (i.e. coloboma, optic atrophy/hypoplasia, ventricular septal defect, gastroesophageal reflux disease, and hypotonia). Nine variants (missense, nonsense, and frameshift) that have been reported in 9 probands in 3 publications (PMIDs: 27087320, 29330883, 31452935) are included in this curation. The mechanism of pathogenicity is believed to be loss of function. This gene-disease relationship is also supported by a mouse model recapitulating the human phenotype (postnatal growth deficiency, brain hypoplasia, decreased numbers of hippocampal neurons, hearing loss, cardiovascular malformations, ventriculomegaly, incomplete closure of the optic fissure, and renal agenesis) and biochemical function demonstrating *RERE*’s role in development through retinoic acid signaling (PMIDs: 20164929, 23451234). In summary, there is definitive evidence supporting the relationship between *RERE* and autosomal dominant complex neurodevelopmental disorder with or without congenital anomalies. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on March 21, 2023 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0014857
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Genitourinary; Neurologic; Ophthalmologic
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RERE variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001042681.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 12 | 196 | 27 | 236 | |
| missense | 6 | 18 | 582 | 130 | 12 | 748 |
| nonsense | 4 | 10 | 5 | 19 | ||
| start loss | 0 | |||||
| frameshift | 11 | 21 | 4 | 36 | ||
| splice donor/acceptor (+/-2bp) | 7 | 6 | 13 | |||
| Total | 21 | 57 | 609 | 326 | 39 | 1052 |
Highest pathogenic variant AF is 0.000008754804
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001036146.1 | 22 | MANE Select | |
| Ensembl | ENSP00000383700.2 | 22 | MANE Select | |
| RefSeq | NP_001036147.1 | 9 | Standard | |
| RefSeq | NP_036234.3 | 22 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| rerea | Danio rerio | Structure: hair cell Quality: quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- chromatin remodeling
- regulation of transcription by RNA polymerase II
- NLS-bearing protein import into nucleus
- cerebellar Purkinje cell layer maturation
- cerebellar granule cell precursor proliferation
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription factor binding
- DNA binding
- chromatin binding
- transcription coactivator activity
Cellular Component
- histone deacetylase complex
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000337907
- Coding exons
- 22
- Length
- 465246
- Individuals with no LoFs
- 125713
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 34
- Defined
- 125747
- p
- 0.000135
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.03 | 737 | 909 | 0.810 | 0.0000589 | 10049 |
| Missense (PolyPhen) | 187 | 316.28 | 0.59124 | 3317 | ||
| Synonymous | -2.83 | 453 | 383 | 1.18 | 0.0000269 | 3205 |
| Loss of Function | 7.11 | 3 | 64.7 | 0.0463 | 0.00000377 | 718 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.000062 | rare |
| Latino/Admixed American | 0.00012 | 0.000058 | rare |
| Ashkenazi Jewish | 0.00021 | 0.00020 | rare |
| East Asian | 0.00011 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00038 | 0.00021 | rare |
| South Asian | 0.00025 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death. {ECO:0000269|PubMed:11331249}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; DISEASE: Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (NEDBEH) [MIM:616975]: An autosomal dominant syndrome characterized by developmental delay, intellectual disability, brain anomalies, and neurological abnormalities including seizures, hypotonia, and behavioral problems such as autism spectrum disorders. Brain anomalies include abnormalities and/or thinning of the corpus callosum, diminished white matter volume, abnormal cerebellar vermis, and ventriculomegaly. Congenital defects of the eye, heart and genitourinary system are present in half of the patients. {ECO:0000269|PubMed:27087320}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- LoFtool
- 0.0674
- RVIS EVS
- -2.63
- RVIS percentile EVS
- 0.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.717
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |